T2 Biosystems | ARS: Annual Report to Security Holders
T2 Biosystems | DEF 14A: Definitive information statements
T2 Biosystems | 8-K: T2 Biosystems Announces Third Quarter 2024 Financial Results
T2 Biosystems | 10-Q: Q3 2024 Earnings Report
T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(7.99%),Steven Boyd(7.99%)
T2 Biosystems | PRE 14A: Preliminary proxy statements relating to merger or acquisition
T2 Biosystems | 8-K: Current report
T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)
T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)
T2 Biosystems | 8-K: T2 Biosystems to Host Q3 2024 Earnings Conference Call
T2 Biosystems | 8-K: T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
T2 Biosystems | 8-K: T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Director Elsbree David B
T2 Biosystems | 8-K: T2 Biosystems Receives Fda Approval to Market T2candida Panel to Paediatric Patients
T2 Biosystems | 144: Notice of proposed sale of securities pursuant to Rule 144
T2 Biosystems | 8-K: T2 Biosystems Announces Update on New Product Development Pipeline
T2 Biosystems | 424B5: Prospectus
T2 Biosystems | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JACOB SAFIER(4.3%),NEW DIMENSIONS TRADING LTD.(4.3%)
T2 Biosystems | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JACOB SAFIER(4.3%),NEW DIMENSIONS TRADING LTD.(4.3%)
T2 Biosystems | 10-Q: Q2 2024 Earnings Report
No Data
No Data